Regulatory Updates
🇺🇸 FDA Page 17FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track global pharma regulatory policy changes, FDA, EMA, and other agency guidelines impacting drug development and market access. Stay ahead.
Showing 193–204 of 382 articles
FDA Considers Easing Restrictions on Unproven Peptides
US FDA Proposes New Regulations on Weight-Loss Drug Compounding
Top Biotech Gainers: CODX, NRXP, NVAX - Clinical Trials Update
Eli Lilly Acquires Centessa Pharmaceuticals: Market Analysis
Commissioner's National Priority Voucher Pilot Program: Clinical Trials Insights
FDA Considers Adding Peptides to Bulk Drug Compounding List
FDA Approvals in Oncology: January-March 2026
FSMA Final Rule: New Traceability Requirements Impacting Food Safety
Healthcare Dealmakers Target Megamergers in 2026
FDA Guidance on Next-Gen Sequencing for Gene Therapy Safety
5 FDA Drug Approvals to Watch in 2026
China Approves HERNEXEOS for Lung Cancer Treatment